Vector Models and Indexing for Pharmacovigilance Regulations

Pharmacovigilance regulation data originates from adverse event reports submitted by pharmaceutical manufacturers, medical institutions, patients, and

Data Characteristics

Pharmacovigilance regulation data originates from adverse event reports submitted by pharmaceutical manufacturers, medical institutions, patients, and regulatory bodies. It also includes drug labels, risk management plans, post-marketing study reports, pharmacovigilance system documents (e.g., SOPs, guidelines), and relevant laws and regulations. Data update frequencies vary; adverse event reports may be continuous, while SOPs and regulations update less frequently. Document structures are diverse, including structured reports (e.g., XML E2B files), semi-structured text (e.g., SOPs, guidelines), and unstructured text (e.g., patient descriptions). Core fields include drug name, batch number, adverse event description, reporter information, event date, actions taken, and outcome. Units involve dosage (mg, g), frequency (times/day), and time (days, months, years).

Constraints on Vector Models and Indexing

Pharmacovigilance data's diverse and heterogeneous nature requires strict standardization and cleaning before vectorization. Semi-structured and unstructured documents need more refined text chunking strategies to ensure semantic completeness. Adverse event descriptions often contain extensive medical terminology, abbreviations, and colloquialisms, demanding domain-adapted pre-trained models. The long text nature of regulatory documents can lead to individual chunks being too long, diluting core information, or too short, losing context. Inconsistent update frequencies necessitate incremental indexing capabilities to avoid frequent full rebuilds. Sensitive information in reports (e.g., patient identity) requires anonymization before vectorization to prevent leakage. Identifying and normalizing field units is crucial for retrieval accuracy and comparability.

Configuration Guidelines

Configuration ItemRecommended ValueRationale
chunk_size500–800 charactersBalances chunk completeness and retrieval efficiency, adapts to various document structures
overlap_size50–100 charactersEnsures semantic continuity between chunks, prevents loss of context
embedding_modeldengcao/Qwen3-Embedding-8BOptimized for Chinese medical domain, better understands professional terminology
similarity_thresholdCalibrate by actual measurementBased on precision and recall curves to ensure relevance
recall_top_ktop 10Ensures sufficient recall range, covers potentially relevant information
rerank_modeldengcao/Qwen3-RerankImproves ranking quality of recalled documents, filters out low-relevance results

Common Pitfalls

  • Semantic fragmentation after chunking. Retrieval results fail to provide complete answers. This occurs when chunk_size is too small or document paragraph structure is not considered.
  • Retrieval results contain excessive irrelevant information. This occurs when similarity_threshold is set too low, recalling chunks with low relevance to the query.
  • Index updates take too long. Each new document requires a long wait. This occurs when incremental indexing strategies are not configured or bottlenecks exist in the document processing pipeline.

Configuration Validation

  • Select a set of standard pharmacovigilance-related questions. Evaluate the proportion of correct answers included in the recall results.
  • Examine the contextual completeness of returned chunks in retrieval results. Determine if critical information is truncated.
  • Monitor index service resource utilization. Confirm that index update time after adding new documents is within an acceptable range.
  • Adjust similarity_threshold. Observe changes in the number of retrieval results. Combine with manual judgment to determine an appropriate threshold range.

The values provided are common starting points and should be measured against specific samples.

Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.